FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132916026> ?p ?o ?g. }

• W3132916026 endingPage "684" @default.
• W3132916026 startingPage "672" @default.
• W3132916026 abstract "Abstract Hepatocellular carcinoma (HCC) developing after hepatitis C virus (HCV) eradication is a serious clinical concern. However, molecular basis for the hepatocarcinogenesis after sustained virologic response (SVR) remains unclear. In this study, we aimed to unveil the transcriptomic profile of post-SVR liver tissues and explore the molecules associated with post-SVR carcinogenesis. We analysed 90 RNA sequencing datasets, consisting of non-cancerous liver tissues including 20 post-SVR, 40 HCV-positive and 7 normal livers, along with Huh7 cell line specimens before and after HCV infection and eradication. Comparative analysis demonstrated that cell cycle- and mitochondrial function-associated pathways were altered only in HCV-positive non-cancerous liver tissues, whereas some cancer-related pathways were up-regulated in the non-cancerous liver tissues of both post-SVR and HCV-positive cases. The persistent up-regulation of carcinogenesis-associated gene clusters after viral clearance was reconfirmed through in vitro experiments, of which, CYR61, associated with liver fibrosis and carcinogenesis in several cancer types, was the top enriched gene and co-expressed with cell proliferation-associated gene modules. To evaluate whether this molecule could be a predictor of hepatocarcinogenesis after cure of HCV infection, we also examined 127 sera from independent HCV-positive cohorts treated with direct-acting antivirals (DAAs), including 60 post-SVR-HCC patients, and found that the elevated serum Cyr61 was significantly associated with early carcinogenesis after receiving DAA therapy. In conclusion, some oncogenic transcriptomic profiles are sustained in liver tissues after HCV eradication, which might be a molecular basis for the liver cancer development even after viral clearance. Among them, up-regulated CYR61 could be a possible biomarker for post-SVR-HCC." @default.
• W3132916026 created "2021-03-01" @default.
• W3132916026 creator A5001467370 @default.
• W3132916026 creator A5002789996 @default.
• W3132916026 creator A5006225276 @default.
• W3132916026 creator A5008067394 @default.
• W3132916026 creator A5008788188 @default.
• W3132916026 creator A5017832183 @default.
• W3132916026 creator A5018814385 @default.
• W3132916026 creator A5024298099 @default.
• W3132916026 creator A5041495820 @default.
• W3132916026 creator A5043965300 @default.
• W3132916026 creator A5053697171 @default.
• W3132916026 creator A5056173852 @default.
• W3132916026 creator A5061999363 @default.
• W3132916026 creator A5075668891 @default.
• W3132916026 creator A5076551859 @default.
• W3132916026 creator A5080250007 @default.
• W3132916026 creator A5080874384 @default.
• W3132916026 creator A5086183940 @default.
• W3132916026 date "2021-02-22" @default.
• W3132916026 modified "2023-10-18" @default.
• W3132916026 title "Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus" @default.
• W3132916026 cites W1760890369 @default.
• W3132916026 cites W1966327575 @default.
• W3132916026 cites W1986689140 @default.
• W3132916026 cites W2000307707 @default.
• W3132916026 cites W2003579943 @default.
• W3132916026 cites W2022040029 @default.
• W3132916026 cites W2028066185 @default.
• W3132916026 cites W2033444406 @default.
• W3132916026 cites W2073889874 @default.
• W3132916026 cites W2125632841 @default.
• W3132916026 cites W2130410032 @default.
• W3132916026 cites W2137678638 @default.
• W3132916026 cites W2143647993 @default.
• W3132916026 cites W2158217645 @default.
• W3132916026 cites W2160191258 @default.
• W3132916026 cites W2172144328 @default.
• W3132916026 cites W2284821093 @default.
• W3132916026 cites W2484268703 @default.
• W3132916026 cites W2510261413 @default.
• W3132916026 cites W2528406770 @default.
• W3132916026 cites W2557569375 @default.
• W3132916026 cites W2562967659 @default.
• W3132916026 cites W2583273198 @default.
• W3132916026 cites W2597456691 @default.
• W3132916026 cites W2657055765 @default.
• W3132916026 cites W2744914748 @default.
• W3132916026 cites W2751505630 @default.
• W3132916026 cites W2797952741 @default.
• W3132916026 cites W2810664537 @default.
• W3132916026 cites W2889646458 @default.
• W3132916026 cites W2897805491 @default.
• W3132916026 cites W2905667684 @default.
• W3132916026 cites W2913327035 @default.
• W3132916026 cites W2917335837 @default.
• W3132916026 cites W2918873588 @default.
• W3132916026 cites W2929496863 @default.
• W3132916026 cites W2949406476 @default.
• W3132916026 cites W2959566316 @default.
• W3132916026 cites W2965258952 @default.
• W3132916026 cites W2981329637 @default.
• W3132916026 cites W2981554019 @default.
• W3132916026 cites W2991643360 @default.
• W3132916026 cites W2996372803 @default.
• W3132916026 cites W783150221 @default.
• W3132916026 doi "https://doi.org/10.1093/carcin/bgab014" @default.
• W3132916026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33617626" @default.
• W3132916026 hasPublicationYear "2021" @default.
• W3132916026 type Work @default.
• W3132916026 sameAs 3132916026 @default.
• W3132916026 citedByCount "6" @default.
• W3132916026 countsByYear W31329160262021 @default.
• W3132916026 countsByYear W31329160262022 @default.
• W3132916026 countsByYear W31329160262023 @default.
• W3132916026 crossrefType "journal-article" @default.
• W3132916026 hasAuthorship W3132916026A5001467370 @default.
• W3132916026 hasAuthorship W3132916026A5002789996 @default.
• W3132916026 hasAuthorship W3132916026A5006225276 @default.
• W3132916026 hasAuthorship W3132916026A5008067394 @default.
• W3132916026 hasAuthorship W3132916026A5008788188 @default.
• W3132916026 hasAuthorship W3132916026A5017832183 @default.
• W3132916026 hasAuthorship W3132916026A5018814385 @default.
• W3132916026 hasAuthorship W3132916026A5024298099 @default.
• W3132916026 hasAuthorship W3132916026A5041495820 @default.
• W3132916026 hasAuthorship W3132916026A5043965300 @default.
• W3132916026 hasAuthorship W3132916026A5053697171 @default.
• W3132916026 hasAuthorship W3132916026A5056173852 @default.
• W3132916026 hasAuthorship W3132916026A5061999363 @default.
• W3132916026 hasAuthorship W3132916026A5075668891 @default.
• W3132916026 hasAuthorship W3132916026A5076551859 @default.
• W3132916026 hasAuthorship W3132916026A5080250007 @default.
• W3132916026 hasAuthorship W3132916026A5080874384 @default.
• W3132916026 hasAuthorship W3132916026A5086183940 @default.
• W3132916026 hasBestOaLocation W31329160261 @default.
• W3132916026 hasConcept C104317684 @default.
• W3132916026 hasConcept C121608353 @default.

• next